Parafricta Bootees vs UK Standard Care to Prevent Heel Pressure Ulcers
Launched by CARDIFF AND VALE UNIVERSITY HEALTH BOARD · Jul 17, 2019
Trial Information
Current as of July 04, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- The eligibility criteria for this study at the time of recruitment were:
- • Adult of age 18 years or over
- • Admitted to secondary care in an in-patient hospital (with no specified interval from admission to hospital to study recruitment)
- • Bedbound or unable to walk independently and requiring assistance to transfer to a chair
- • 'Very high' risk group for pressure ulceration (defined by a Waterlow Score of 20 or more)
- • No existing heel pressure ulcers of EPUAP/NPUAP/PPPIA Category 1 or above or any other type of wound on the feet.
- • Patient was not being treated with pressure offloading boots.
- • Patient was not being treated with a heel cast.
- Exclusion Criteria:
- • • Patients with a single or double lower limb amputation were not eligible to participate in the study.
About Cardiff And Vale University Health Board
Cardiff and Vale University Health Board is a prominent healthcare organization based in Wales, dedicated to delivering high-quality medical services and leading innovative research initiatives. As a clinical trial sponsor, the Health Board plays a critical role in advancing medical knowledge and improving patient care through rigorous scientific investigation. With a commitment to ethical standards and patient safety, Cardiff and Vale University Health Board collaborates with multidisciplinary teams to facilitate a wide range of clinical studies, fostering an environment that supports both clinical excellence and research advancements. Their focus on translational research ensures that findings are effectively integrated into practice, ultimately benefiting the health and well-being of the communities they serve.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cardiff, , United Kingdom
Patients applied
Trial Officials
Grace Carolan-Rees, Prof
Study Director
Cedar, Cardiff & Vale University Health Board
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials